News | August 29, 2014

Brain Sodium Channels in Heart Linked to Sudden Cardiac Death

DNA, sudden cardiac death
August 29, 2014 – A research study published in the July issue Journal of the American College of Cardiology reports that genetic mutations in a neuronal sodium channel gene are associated with inherited sudden cardiac death syndromes, including the Brugada syndrome. The study, performed at the Cardiac Research Institute at Masonic Medical Research Laboratory (MMRL) in Utica, NY, included physicians and scientists from throughout the world who referred patients with life-threatening cardiac arrhythmias to the MMRL for genetic screening. 
 
The Brugada syndrome is associated with an inherited irregular heart rhythm. In some cases the first warning sign is sudden cardiac death. The syndrome affects approximately 5 in 10,000 individuals. The MMRL, one of the top genetic screening centers in the world devoted to inherited sudden cardiac death syndromes, identified the majority of genes responsible for the Brugada syndrome. The MMRL works with families who have tragically lost someone to this insidious disease, testing children, siblings and other relatives to see if they are also at risk. 
 
Prior to this discovery, a genetic defect could be identified in only 35% of Brugada syndrome patients. The new gene associated with the syndrome, called SCN10A, accounts for an additional 17 percent, thus greatly improving our ability to identify a susceptibility gene to over 50 percent of affected index patients. SCN10A encodes a sodium channel previously thought to be associated exclusively with the brain and nervous system. This and other recent studies suggest that it is also present in the heart and when defective can result in life-threatening heart rhythm disorders. 
 
Dr. Dan Hu, the lead author on this study, said these findings provide important insights into the pathophysiology of these syndromes as well as new targets for therapy. Dr. Charles Antzelevitch, Executive Director and Director of research of the MMRL, and senior author of the study added, “The identification of SCN10A as a major susceptibility gene for Brugada syndrome greatly enhances our ability to identify patients and family members who are at risk. These findings also open the door to delineation of the role of other presumably neuronal sodium channels in the electrical function of the heart in both health and disease.” 
 
Although a susceptibility gene can now be identified in over 50 percent of affected index patients, in nearly 50 percent the culprit gene remains unknown. “A negative study does not mean you don’t have the disease; it just means that the genetic marker cannot be identified,” said Antzelevitch. He added that “a great deal of research remains to be done to identify the other genes involved.” 
 
For more information: http://content.onlinejacc.org/issues.aspx

Related Content

New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
PTSD Alone Does Not Increase Heart Disease Risk in Veterans
News | Cardiac Diagnostics | February 20, 2019
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the...
Hormone Therapy May Increase Cardiovascular Risk During Gender Transition
News | Cardiac Diagnostics | February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular...
IBM and Broad Institute Launch AI Initiative for Cardiovascular Disease Risk Prediction
News | Cardiac Diagnostics | February 15, 2019
IBM Watson Health and the Broad Institute of MIT and Harvard are launching a research partnership aimed at developing...
Nearly Half of All U.S. Adults Have Cardiovascular Disease
News | Cardiac Diagnostics | January 31, 2019
January 31, 2019 — Nearly half (48 percent, 121.5 million in 2016) of all adults in the United States have some type
Frequent Red Meat Consumption Triples Levels of Chemical Associated With Heart Disease
News | Cardiac Diagnostics | January 23, 2019
Researchers have identified another reason to limit red meat consumption: high levels of a gut-generated chemical...
Overlay Init